“I need to know if I’m going to die young”: Adolescent and young adult experiences of genetic testing for Li–Fraumeni syndrome

References

• Zebrack BJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer. 2011;117(10 Suppl):2289–2294. doi:10.1002/cncr.26056
   PubMed Web of Science ®Google Scholar
• Arnett JJ. Emerging adulthood: a theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–480.
   PubMed Web of Science ®Google Scholar
• Patton G, Temmerman M. Evidence and evidence gaps in adolescent health. J Adolesc Health. 2016;59(4S):S1–S3. doi:10.1016/j.jadohealth.2016.08.001
   PubMedGoogle Scholar
• Zebrack B, Isaacson S. Psychosocial care of adolescent and young adult patients with cancer and survivors. J Clin Oncol. 2012;30(11):1221–1226. doi:10.1200/JCO.2011.39.5467
   PubMed Web of Science ®Google Scholar
• Zebrack BJ, Block R, Hayes-Lattin B, et al. Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients. Cancer. 2013;119(1):201–214. doi:10.1002/cncr.27713
   PubMed Web of Science ®Google Scholar
• Kent EE, Parry C, Montoya MJ, Sender LS, Morris RA, Anton-Culver H. “You're too young for this”: adolescent and young adults' perspectives on cancer survivorship. J Psychosoc Oncol. 2012;30(2):260–279. doi:10.1080/07347332.2011.644396
   PubMed Web of Science ®Google Scholar
• Mai PL, Best AF, Peters JA, et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li–Fraumeni syndrome cohort. Cancer. 2016;122(23):3673–3681. doi:10.1002/cncr.30248
   PubMed Web of Science ®Google Scholar
• Bougeard G, Renaux-Petel M, Flaman JM, et al. Revisiting Li–Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345–U2333. doi:10.1200/JCO.2014.59.5728
   PubMed Web of Science ®Google Scholar
• Ballinger ML, Best A, Mai PL, et al. Baseline surveillance in Li–Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol. 2017;3(12):1634–1639. doi:10.1001/jamaoncol.2017.1968
   PubMed Web of Science ®Google Scholar
• Villani A, Shore A, Wasserman JD, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016;17(9):1295–1305. doi:10.1016/S1470-2045(16)30249-2
   PubMed Web of Science ®Google Scholar
• Lammens CR, Aaronson NK, Wagner A, et al. Genetic testing in Li–Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol. 2010;28(18):3008–3014. doi:10.1200/JCO.2009.27.2112
   PubMed Web of Science ®Google Scholar
• Peterson SK, Pentz RD, Marani SK, et al. Psychological functioning in persons considering genetic counseling and testing for Li–Fraumeni syndrome. Psychooncology. 2008;17(8):783–789. doi:10.1002/pon.1352
   PubMed Web of Science ®Google Scholar
• Ross J, Bojadzieva J, Peterson S, et al. The psychosocial effects of the Li–Fraumeni education and early detection (LEAD) program on individuals with Li–Fraumeni syndrome. Genet Med. 2017;19(9):1064–1071. doi:10.1038/gim.2017.8
   PubMed Web of Science ®Google Scholar
• McBride KA, Ballinger ML, Schlub TE, et al. Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Fam Cancer. 2017;16(3):423–432. doi:10.1007/s10689-016-9964-7
   PubMed Web of Science ®Google Scholar
• Bancroft EK, Saya S, Brown E, et al. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). J Med Genet. 2019;57(4):226–236. doi:10.1136/jmedgenet-2019-106407
   PubMed Web of Science ®Google Scholar
• Valdez JM, Walker B, Ogg S, et al. Parent-child communication surrounding genetic testing for Li–Fraumeni syndrome: living under the cloud of cancer. Pediatr Blood Cancer. 2018;65(11):e27350. doi:10.1002/pbc.27350
   PubMed Web of Science ®Google Scholar
• Alderfer MA, Zelley K, Lindell RB, et al. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer. 2015;121(2):286–293. doi:10.1002/cncr.29027
   PubMed Web of Science ®Google Scholar
• Godino L, Jackson L, Turchetti D, Hennessy C, Skirton H. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study. Eur J Hum Genet. 2018;26(1):44–53. doi:10.1038/s41431-017-0030-1
   PubMed Web of Science ®Google Scholar
• McGill BC, Wakefield CE, Vetsch J, et al. Children and young people’s understanding of inherited conditions and their attitudes towards genetic testing: a systematic review. Clin Genet. 2019;95(1):10–22. doi:10.1111/cge.13253
   PubMed Web of Science ®Google Scholar
• Forbes Shepherd R, Lewis A, Keogh LA, Werner-Lin A, Delatycki MB, Forrest LE. A systematic review of how young people live with inherited disease: what can we learn for Li–Fraumeni syndrome? J Adolesc Young Adult Oncol. 2018;7(5):525–545. doi:10.1089/jayao.2018.0028
   PubMed Web of Science ®Google Scholar
• Godino L, Turchetti D, Jackson L, Hennessy C, Skirton H. Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents. Eur J Hum Genet. 2019;27(2):291–299. doi:10.1038/s41431-018-0262-8
   PubMed Web of Science ®Google Scholar
• Botkin Jeffrey R, Belmont John W, Berg Jonathan S, et al. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 2015;97(1):6–21. doi:10.1016/j.ajhg.2015.05.022
   PubMed Web of Science ®Google Scholar
• Alderfer MA, Lindell RB, Viadro CI, et al. Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with Li–Fraumeni syndrome. J Genet Couns. 2017;26(5):1106–1115. doi:10.1007/s10897-017-0091-x
   PubMed Web of Science ®Google Scholar
• Renaux-Petel M, Charbonnier F, Théry JC, et al. Contribution of de novo and mosaic TP53 mutations to Li–Fraumeni syndrome. J Med Genet. 2018;55(3):173–180. doi:10.1136/jmedgenet-2017-104976
   PubMed Web of Science ®Google Scholar
• Schultz CL, Alderfer MA, Lindell RB, et al. The influence of adolescence on parents’ perspectives of testing and discussing inherited cancer predisposition. J Genet Counsel. 2018;27(6):1395–1404. doi:10.1007/s10897-018-0267-z
   Web of Science ®Google Scholar
• Maxwell JA. What is realism, and why should qualitative researchers care? In: A Realist Approach for Qualitative Research. Thousand Oaks, CA: SAGE; 2012:3–13.
   Google Scholar
• Thorne S, Kirkham SR, O'Flynn-Magee K. The analytic challenge in interpretive description. Int J Qual Methods. 2004;3(1):1–11. doi:10.1177/160940690400300101
   Google Scholar
• Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753–1760. doi:10.1177/1049732315617444
   PubMed Web of Science ®Google Scholar
• Bryant A, Charmaz K. The SAGE Handbook of Grounded Theory. Thousand Oaks, CA: SAGE; 2007.
   Google Scholar
• Braun V, Clarke V, Hayfield N, Terry G. Thematic analysis. In: Liamputtong P, ed. Handbook of Research Methods in Health Social Sciences. Singapore: Springer Singapore; 2019:843–860.
   Google Scholar
• MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. Field Methods. 1998;10(2):31–36. doi:10.1177/1525822X980100020301
   Google Scholar
• Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology. 2005;14(12):1060–1074. doi:10.1002/pon.933
   PubMed Web of Science ®Google Scholar
• Brunstrom K, Murray A, McAllister M. Experiences of women who underwent predictive BRCA 1/2 mutation testing before the age of 30. J Genet Couns. 2016;25(1):90–100. doi:10.1007/s10897-015-9845-5
   PubMed Web of Science ®Google Scholar
• Mand CM, Gillam L, Duncan RE, Delatycki MB. “It was the missing piece”: adolescent experiences of predictive genetic testing for adult-onset conditions. Genet Med. 2013;15(8):643–649. doi:10.1038/gim.2013.15
   PubMed Web of Science ®Google Scholar
• Cancer Institute New South Wales. Risk Management for Li–Fraumeni Syndrome: ID-000749 (V.7). 2019. https://www.eviq.org.au/cancer-genetics/risk-management/749-risk-management-for-adults-with-a-tp53-mutatio. Accessed May 1, 2019.
   Google Scholar
• Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Soc Sci Med. 2004;59(3):553–565. doi:10.1016/j.socscimed.2003.11.025
   PubMed Web of Science ®Google Scholar
• Mireskandari S, Sangster J, Meiser B, et al. Psychosocial impact of familial adenomatous polyposis on young adults: a qualitative study. J Genet Couns. 2009;18(5):409–417. doi:10.1007/s10897-009-9231-2
   PubMed Web of Science ®Google Scholar
• Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics. 2003;29(2):74–79. doi:10.1136/jme.29.2.74
   PubMed Web of Science ®Google Scholar
• Mand CM, Gillam L, Duncan RE, Delatycki MB. “I'm scared of being like mum”: the experience of adolescents living in families with Huntington Disease. J Huntingtons Dis. 2015;4(3):209–217. doi:10.3233/JHD-150148
   PubMed Web of Science ®Google Scholar
• McGill BC, Wakefield CE, Vetsch J, et al. “I remember how I felt, but I don't remember the gene”: families' experiences of cancer-related genetic testing in childhood. Pediatr Blood Cancer. 2019;66(8):e27762doi:10.1002/pbc.27762
   PubMed Web of Science ®Google Scholar
• Hamilton R, Williams JK, Bowers BJ, Calzone K. Life trajectories, genetic testing, and risk reduction decisions in 18–39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns. 2009;18(2):147–159. doi:10.1007/s10897-008-9200-1
   PubMed Web of Science ®Google Scholar
• Forrest Keenan K, McKee L, Miedzybrodzka Z. Help or hindrance: young people’s experiences of predictive testing for Huntington's disease. Clin Genet. 2015;87(6):563–569. doi:10.1111/cge.12439
   PubMed Web of Science ®Google Scholar
• MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L. Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer. Eur J Hum Genet. 2014;22(3):396–401. doi:10.1038/ejhg.2013.143InsertedFromOnline
   PubMed Web of Science ®Google Scholar
• Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer. 2010;9(1):27–35. doi:10.1007/s10689-009-9294-0
   PubMed Web of Science ®Google Scholar
• Werner-Lin A, Hoskins LM, Doyle MH, Greene MH. “Cancer doesn't have an age”: genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18–24. Health (London). 2012;16(6):636–654. doi:10.1177/1363459312442420
   PubMed Web of Science ®Google Scholar
• Werner-Lin A, Tomlinson A, Miller V, Bernhardt BA. Adolescent engagement during assent for exome sequencing. AJOB Empir Bioeth. 2016;7(4):275–284. doi:10.1080/23294515.2016.1197983
   Google Scholar
• Duncan RE, Young MA. Tricky teens: are they really tricky or do genetic health professionals simply require more training in adolescent health? Per Med. 2013;10(6):589–600. doi:10.2217/pme.13.49
   PubMed Web of Science ®Google Scholar
• Young M-A, Thompson K, Lewin J, Holland L. A framework for youth-friendly genetic counseling. J Community Genet. 2020;11(2):161–170. Published Online First: 5 November 2019. doi:10.1007/s12687-019-00439-2
   PubMed Web of Science ®Google Scholar
• Wakefield CE, Fardell JE, Doolan EL, et al. Participation in psychosocial oncology and quality-of-life research: a systematic review. Lancet Oncol. 2017;18(3):e153–e165. doi:10.1016/S1470-2045(17)30100-6
   PubMed Web of Science ®Google Scholar